病例报告

紫杉醇腹腔热灌注联合静脉化疗转化治疗晚期胃癌(附1例报告)

展开
  • 上海交通大学医学院附属瑞金医院北院普外科,上海 201800

收稿日期: 2019-09-30

  网络出版日期: 2020-04-25

Conversion therapy for far-advanced gastric cancer with paclitaxel hyperthermia intraperitoneal and intravenous chemotherapy: a case report

Expand

Received date: 2019-09-30

  Online published: 2020-04-25

本文引用格式

姜松耀, 赵良超, 严晓伟, 胡皆乐, 项明 . 紫杉醇腹腔热灌注联合静脉化疗转化治疗晚期胃癌(附1例报告)[J]. 外科理论与实践, 2020 , 25(02) : 152 -154 . DOI: 10.16139/j.1007-9610.2020.02.013

参考文献

[1] Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer, 2015, 136(5):E359-E386.
[2] Imano M, Okuno K. Treatment strategies for gastric cancer patients with peritoneal metastasis[J]. Surg Today, 2014, 44(3):399-404.
[3] Bndo E, Yonemura Y, Takeshita Y, et al. Intraoperative lavage for cytological examination in 1297 patients with gastric carcinoma[J]. Am J Surg, 1999, 178(3):256-262.
[4] Maruyama K, Kaminishi M, Hayashi K, et al. Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry[J]. Gastric cancer, 2006, 9(2):51-66.
[5] Cotte E, Peyrat P, Piaton E, et al. Lack of prognostic significance of conventional peritoneal cytology in colorectal and gastric cancers: results of EVOCAPE 2 multicentre prospective study[J]. Eur J Surg Oncol, 2013, 39(7):707-714.
[6] Thomassen I, van Gestel YR, van Ramshorst B, et al. Peritoneal carcinomatosis of gastric origin: A population-based study on incidence, survival and risk factors[J]. Int J Cancer, 2014, 134(3):622-628.
[7] Glehen O, Schreiber V, Cotte E, et al. Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer[J]. Arch Surg, 2004, 139(1):20-26.
[8] Sugarbaker PH, vander Speeten K. Surgical technology and pharmacology of hyperthermic perioperative chemotherapy[J]. J Gastrointest Oncol, 2016, 7(1):29-44.
[9] Kobayashi D, Kodera Y. Intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis[J]. Gastric Cancer, 2017, 20(Suppl 1):S111-S121.
[10] Sun J, Song Y, Wang Z, et al. Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the rando-mized controlled trials[J]. BMC Cancer, 2012, 12,526.
[11] 朱正纲. 紫杉醇与替吉奥联合防治胃癌腹膜转移的临床疗效[J]. 中华胃肠外科杂志, 2015, 18(10):979-982.
[12] Yonemura Y, Bandou E, Kawamura T, et al. Quantitative prognostic indicators of peritoneal dissemination of gastric cancer[J]. Eur J Surg Oncol, 2006, 32(6):602-606.
[13] 严超, 燕敏, 朱正纲. 胃癌术前分期的临床应用及其价值[J]. 中华胃肠外科杂志, 2013, 16(2):114-117.
文章导航

/